171 related articles for article (PubMed ID: 34582652)
1. Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.
Dawood RM; Abd El Meguid M; Elrobe W; Salum GM; Zayed N; Mousa S; Medhat E
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2837-2845. PubMed ID: 34582652
[TBL] [Abstract][Full Text] [Related]
2. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY
World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291
[TBL] [Abstract][Full Text] [Related]
6. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
7. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
9. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
11. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
[TBL] [Abstract][Full Text] [Related]
13. Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients.
Pirisi M; Toniutto P; Uzzau A; Fabris C; Avellini C; Scott C; Apollonio L; Beltrami CA; Bresadola F
Cancer; 2000 Jul; 89(2):297-302. PubMed ID: 10918159
[TBL] [Abstract][Full Text] [Related]
14. HFE genotype in patients with hemochromatosis and other liver diseases.
Bacon BR; Olynyk JK; Brunt EM; Britton RS; Wolff RK
Ann Intern Med; 1999 Jun; 130(12):953-62. PubMed ID: 10383365
[TBL] [Abstract][Full Text] [Related]
15. Transient elevation of serum ferritin in a Sri Lankan with homozygosity for H63D mutation in the HFE gene: a case report.
Wickramasinghe W; Karunathilaka C; Jayasinghe S; Gooneratne L
J Med Case Rep; 2020 Jul; 14(1):93. PubMed ID: 32641120
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma.
Gharib AF; Karam RA; Pasha HF; Radwan MI; Elsawy WH
Gene; 2011 Dec; 489(2):98-102. PubMed ID: 21925577
[TBL] [Abstract][Full Text] [Related]
17. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
[TBL] [Abstract][Full Text] [Related]
18. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
19. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
